loader
Please Wait
Applying Filters...

Athena Athena

X

Approved Drug Products containing 21402 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ABBVIE (12)

filter

01 TABLET;ORAL (12)

filter

01 RX (12)

filter

01 SYNTHROID (12)

filter

01 Yes (12)

URL Supplier Web Content
TABLET; ORAL
0.3MG **See curren...
2002-07-24
21402
SYNTHROID
RX
Yes
AB1,A
Abbvie Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
0.112MG **See curr...
2002-07-24
21402
SYNTHROID
RX
Yes
AB1,A
Abbvie Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
0.15MG **See curre...
2002-07-24
21402
SYNTHROID
RX
Yes
AB1,A
Abbvie Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
0.088MG **See curr...
2002-07-24
21402
SYNTHROID
RX
Yes
AB1,A
Abbvie Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
0.05MG **See curre...
2002-07-24
21402
SYNTHROID
RX
Yes
AB1,A
Abbvie Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
0.2MG **See curren...
2002-07-24
21402
SYNTHROID
RX
Yes
AB1,A
Abbvie Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
0.175MG **See curr...
2002-07-24
21402
SYNTHROID
RX
Yes
AB1,A
Abbvie Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
0.1MG **See curren...
2002-07-24
21402
SYNTHROID
RX
Yes
AB1,A
Abbvie Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
0.075MG **See curr...
2002-07-24
21402
SYNTHROID
RX
Yes
AB1,A
Abbvie Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
0.025MG **See curr...
2002-07-24
21402
SYNTHROID
RX
Yes
AB1,A
Abbvie Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier

Looking for FDA Orange Book APPLICATION 21402

Looking for FDA Orange Book APPLICATION 21402 10

19

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.

Regulatory Information RX

With a dosage strength 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2002-07-24

Therapeutic Equivalence (TE) Code AB1,A

18

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.

Regulatory Information RX

With a dosage strength 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2002-07-24

Therapeutic Equivalence (TE) Code AB1,A

17

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.

Regulatory Information RX

With a dosage strength 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2002-07-24

Therapeutic Equivalence (TE) Code AB1,A

16

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.

Regulatory Information RX

With a dosage strength 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2002-07-24

Therapeutic Equivalence (TE) Code AB1,A

15

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.

Regulatory Information RX

With a dosage strength 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2002-07-24

Therapeutic Equivalence (TE) Code AB1,A

14

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.

Regulatory Information RX

With a dosage strength 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2002-07-24

Therapeutic Equivalence (TE) Code AB1,A

13

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.

Regulatory Information RX

With a dosage strength 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2002-07-24

Therapeutic Equivalence (TE) Code AB1,A

12

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.

Regulatory Information RX

With a dosage strength 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2002-07-24

Therapeutic Equivalence (TE) Code AB1,A

11

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.

Regulatory Information RX

With a dosage strength 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2002-07-24

Therapeutic Equivalence (TE) Code AB1,A

10

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.

Regulatory Information RX

With a dosage strength 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2002-07-24

Therapeutic Equivalence (TE) Code AB1,A

Post Enquiry
POST ENQUIRY